Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of GT Biopharma Inc (NASDAQ: GTBP) was $2.24 for the day, up 0.45% from the previous closing price of $2.23. In other words, the price has increased by $0.45 from its previous closing price. On the day, 0.53 million shares were traded.
Ratios:
Our analysis of GTBP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 0.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Stock Price History:
Over the past 52 weeks, GTBP has reached a high of $10.66, while it has fallen to a 52-week low of $1.72. The 50-Day Moving Average of the stock is -3.73%, while the 200-Day Moving Average is calculated to be -7.39%.
Shares Statistics:
A total of 2.54M shares are outstanding, with a floating share count of 2.05M. Insiders hold about 20.69% of the company’s shares, while institutions hold 11.20% stake in the company.
